Trovagene, Inc. (TROV): Bridger Management Reports 11% Stake and Goes Activist

Page 2 of 6 – SEC Filing

CUSIP No. 897238309
Page 2
1
NAME OF REPORTING PERSON
Bridger Management, LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) ☐ (b) ☒
3
SEC USE ONLY
4
SOURCE OF FUNDS
OO (See Item 3)
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
7
SOLE VOTING POWER
0
8
SHARED VOTING POWER
3,290,587
9
SOLE DISPOSITIVE POWER
0
10
SHARED DISPOSITIVE POWER
3,290,587
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,290,587
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11.0%  (1)
14
TYPE OF REPORTING PERSON
IA
(1)
Based on the 29,782,810 shares of common stock disclosed by the Issuer as outstanding as of March 21, 2016, as reported by the Issuer in its Form DEF 14A filed with the Securities and Exchange Commission on March 31, 2016.
Follow Cardiff Oncology Inc. (NASDAQ:CRDF)